Latest news
2017 - Development of antibody-based immunotherapy for Parkinson's disease - Martin Ingelsson - Uppsala University, Sweden
In Parkinson's disease, alpha-synuclein accumulates in the neurons of the brain and intermediate forms of this protein, called oligomers, are particularly harmful. We...
2017 - Molecular mechanisms and new treatment strategies of type 2 diabetes - Margit Mahlapuu - University of Gothenburg
The prevalence of type 2 diabetes (T2D) is increasing dramatically and T2D has become one of the major global health threats. Intensive...
2017 - Unknown epitopes and cause of disease - Mats Wahlgren - Karolinska Institutet
Here we propose to create an intelligent set of randomly selected "disease structures" (peptides) to identify mainly tertiary and quaternary epitopes...
2017 - Identification of metabolically important factors secreted by muscles during exercise - Juleen Zierath - Karolinska Institutet
Type 2 diabetes occurs when the body's tissues develop a strong resistance to the hormone insulin and also a reduced production of...
2016 - Development of novel therapy for inflammatory systemic diseases using HMGB1 antagonists - Ulf Andersson - Karolinska Institutet
An alarmin is a preformed molecule with a given intracellular cellular function but which can be released extracellularly as a...
2016 – Torsten Söderberg’s Academy Professorship in Medicine 2017 – Göran K. Hansson – Royal Swedish Academy of Sciences
The Torsten Söderberg Foundation currently funds five academic professorships in medicine at a level of 2 million Swedish kronor per year for five years....
2016 - Multicellular disease models to find and functionally validate new drug targets in immune diseases - Mikael Benson - Linköping University
Treatment of inflammatory diseases is complicated by the fact that many different molecules and cell types are involved, and that these can differ...
2016 - Type 2 diabetes - new markers and mechanisms - Ulf Smith - University of Gothenburg
The application (two years) is focused on our novel findings with clear clinical translational relevance. We expect that within the period...
2016 - A novel approach to choose the best individual antidepressant treatment - Sandra Ceccatelli - Karolinska Institutet
Major depressive disorder (MDD) is a major cause of disability and affects the working-age population worldwide....
2016 - New treatment strategy for obstetric asphyxia and stroke - Marcela Pekna - University of Gothenburg
Brain ischemia, i.e. oxygen deprivation due to lack of blood circulation after stroke or childbirth (asphyxia), is a major cause of...
2016 - Development of pairwise binding drugs - Ulf Landegren - Uppsala University, Sweden
Drug development is expensive and difficult. New approaches are needed to more effectively develop highly specific medicines for a wide range of...
2016 - Lysozyme: A new treatment strategy for Alzheimer's disease - Ann-Christin Brorsson - Linköping University
My research team has recently discovered that the protein lysozyme may have a neuroprotective effect in Alzheimer's disease (AD). AD is characterized by...
